Five-mer peptides prevent short-term spatial memory deficits in Aβ25-35-induced Alzheimer’s model mouse by suppressing Aβ25-35 aggregation and resolving its aggregate form
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Five-mer peptides prevent short-term spatial memory deficits in Aβ25-35-induced Alzheimer’s model mouse by suppressing Aβ25-35 aggregation and resolving its aggregate form
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-04-19
DOI
10.1186/s13195-023-01229-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure–Activity Relationship of 5-mer Catalytides, GSGYR and RYGSG
- (2022) Rina Nakamura et al. Biomolecules
- Microglia and immunotherapy in Alzheimer’s disease
- (2021) Qingqing Li et al. ACTA NEUROLOGICA SCANDINAVICA
- Hypothesis: Modulation of microglial phenotype in Alzheimer's disease drives neurodegeneration
- (2021) Andrew G. Murchison Alzheimers & Dementia
- Neuroprotective Effects of Ceftriaxone Involve the Reduction of Aβ Burden and Neuroinflammatory Response in a Mouse Model of Alzheimer’s Disease
- (2021) Maria A. Tikhonova et al. Frontiers in Neuroscience
- Ginsenoside Rb1 protected PC12 cells from Aβ25-35-induced cytotoxicity via PPARγ activation and cholesterol reduction
- (2020) Ke Changhong et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The discovery of shorter synthetic proteolytic peptides derived from Tob1 protein
- (2019) Rina Nakamura et al. PEPTIDES
- Microglia in Alzheimer's disease: A target for immunotherapy
- (2019) Shoutang Wang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
- (2019) Sohaib Nizami et al. BRITISH JOURNAL OF PHARMACOLOGY
- Microglial phagocytosis in aging and Alzheimer's disease
- (2019) Enrique Gabandé‐Rodríguez et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
- (2019) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of protein misfolding and aggregation by natural phenolic compounds
- (2018) Zohra Dhouafli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Attenuation of zinc-enhanced inflammatory M1 phenotype of microglia by peridinin protects against short-term spatial-memory impairment following cerebral ischemia in mice
- (2018) Yusuke Ueba et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Influence of extracellular zinc on M1 microglial activation
- (2017) Youichirou Higashi et al. Scientific Reports
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- BTG/Tob family members Tob1 and Tob2 inhibit proliferation of mouse embryonic stem cells via Id3 mRNA degradation
- (2015) Yuanfan Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
- (2015) Sagar H. Barage et al. NEUROPEPTIDES
- Simvastatin prevents β-amyloid25–35-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate
- (2015) Conghui Wang et al. NEUROPHARMACOLOGY
- Structure-Based Peptide Design to Modulate Amyloid Beta Aggregation and Reduce Cytotoxicity
- (2015) Jitendra Kumar et al. PLoS One
- Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry–mass spectrometry
- (2014) Lydia M. Young et al. Nature Chemistry
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- P2X7 receptors regulate engulfing activity of non-stimulated resting astrocytes
- (2013) Mina Yamamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity
- (2013) Ulf Schulze-Topphoff et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Amyloid β-Peptide 25–35 Self-Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer’s Disease Process and Treatment
- (2012) Marina Naldi et al. ACS Chemical Neuroscience
- Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease
- (2012) Giuseppe D'Agostino et al. NEUROPSYCHOPHARMACOLOGY
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Conformations and Biological Activities of Amyloid Beta Peptide 25-35
- (2010) L. Millucci et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Structural Basis for the Antiproliferative Activity of the Tob-hCaf1 Complex
- (2009) Masataka Horiuchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rapid aggregation and assembly in aqueous solution of Aβ (25–35) peptide
- (2009) Lia Millucci et al. JOURNAL OF BIOSCIENCES
- Microglial Dysfunction and Defective -Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
- (2008) S. E. Hickman et al. JOURNAL OF NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now